Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology and Hepatology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Women’s Health Knowledge Hub Advances in Alzheimer’s

Navigating neuroimaging in Alzheimer disease care

PET imaging is playing an increasingly critical role in managing AD, but how can you effectively integrate it into clinical practice? Our expert-led program will empower you with practical strategies and real-world case studies.

This content is intended for healthcare professionals outside of the UK.
ADVANCED SEARCH
Log in
Top
Archives of Dermatological Research
Published in:

01-08-2024 | Psoriatic Arthritis | Review

Differences between psoriatic arthritis and psoriasis in multi-omics

Authors: Siming Gao, Hui Song

Published in: Archives of Dermatological Research | Issue 6/2024

Login to get access

Abstract

We aim to systemically review the genomics, transcriptomics, epigenetics, proteomics, metabonomics and microbiota of psoriatic arthritis and psoriasis, illustrating the differences of these two diseases, broadening our understanding of the pathogenesis of them and providing important clues for valuable biomarkers of earlier diagnosis and treatments. To our knowledge, this is the first study that combine all omics studies from genomics to microbiota and may serve as a reference for future studies to identify the key underlying pathways in psoriatic arthritis.
Literature
1.
Olivieri I, Padula A, D’Angelo S, Cutro MS (2009) Psoriatic arthritis sine psoriasis. J Rheumatol Suppl 83:28–29PubMed
2.
Gladman DD, Antoni C, Mease P, Clegg DO, Nash P (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2):ii14–17PubMedPubMedCentral
3.
Gladman DD, Anhorn KA, Schachter RK, Mervart H (1986) HLA antigens in psoriatic arthritis. J Rheumatol 13(3):586–592PubMed
4.
Eder L, Chandran V, Pellet F, Shanmugarajah S, Rosen CF, Bull SB, Gladman DD (2012) Human leucocyte antigen risk alleles for psoriatic arthritis among patients with psoriasis. Ann Rheum Dis 71(1):50–55PubMed
5.
6.
Nair RP, Duffin KC, Helms C, Ding J, Stuart PE, Goldgar D, Gudjonsson JE, Li Y, Tejasvi T, Feng BJ et al (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 41(2):199–204PubMedPubMedCentral
7.
Gladman DD, Farewell VT (1995) The role of HLA antigens as indicators of disease progression in psoriatic arthritis. Multivariate relative risk model. Arthritis Rheum 38(6):845–850PubMed
8.
FitzGerald O, Haroon M, Giles JT, Winchester R (2015) Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther 17(1):115PubMedPubMedCentral
9.
Gonzalez S, Martinez-Borra J, Torre-Alonso JC, Gonzalez-Roces S, Sanchez del Rio J, Rodriguez Perez A, Brautbar C, Lopez-Larrea C (1999) The MICA-A9 triplet repeat polymorphism in the transmembrane region confers additional susceptibility to the development of psoriatic arthritis and is independent of the association of Cw*0602 in psoriasis. Arthritis Rheum 42(5):1010–1016PubMed
10.
Duffin KC, Chandran V, Gladman DD, Krueger GG, Elder JT, Rahman P (2008) Genetics of psoriasis and psoriatic arthritis: update and future direction. J Rheumatol 35(7):1449–1453PubMedPubMedCentral
11.
Pollock R, Chandran V, Barrett J, Eder L, Pellett F, Yao C, Lino M, Shanmugarajah S, Farewell VT, Gladman DD (2011) Differential major histocompatibility complex class I chain-related A allele associations with skin and joint manifestations of psoriatic disease. Tissue Antigens 77(6):554–561PubMed
12.
Stuart PE, Nair RP, Tsoi LC, Tejasvi T, Das S, Kang HM, Ellinghaus E, Chandran V, Callis-Duffin K, Ike R et al (2015) Genome-Wide Association Analysis of Psoriatic Arthritis and cutaneous psoriasis reveals differences in their Genetic Architecture. Am J Hum Genet 97(6):816–836PubMedPubMedCentral
13.
Bowes J, Budu-Aggrey A, Huffmeier U, Uebe S, Steel K, Hebert HL, Wallace C, Massey J, Bruce IN, Bluett J et al (2015) Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis. Nat Commun 6:6046PubMed
14.
Ellinghaus E, Ellinghaus D, Stuart PE, Nair RP, Debrus S, Raelson JV, Belouchi M, Fournier H, Reinhard C, Ding J et al (2010) Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet 42(11):991–995PubMedPubMedCentral
15.
Stuart PE, Nair RP, Ellinghaus E, Ding J, Tejasvi T, Gudjonsson JE, Li Y, Weidinger S, Eberlein B, Gieger C et al (2010) Genome-wide association analysis identifies three psoriasis susceptibility loci. Nat Genet 42(11):1000–1004PubMedPubMedCentral
16.
Duffin KC, Freeny IC, Schrodi SJ, Wong B, Feng BJ, Soltani-Arabshahi R, Rakkhit T, Goldgar DE, Krueger GG (2009) Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking. J Invest Dermatol 129(12):2777–2783PubMed
17.
Huffmeier U, Lascorz J, Bohm B, Lohmann J, Wendler J, Mossner R, Reich K, Traupe H, Kurrat W, Burkhardt H et al (2009) Genetic variants of the IL-23R pathway: association with psoriatic arthritis and psoriasis vulgaris, but no specific risk factor for arthritis. J Invest Dermatol 129(2):355–358PubMed
18.
Filer C, Ho P, Smith RL, Griffiths C, Young HS, Worthington J, Bruce IN, Barton A (2008) Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum 58(12):3705–3709PubMedPubMedCentral
19.
Pollock RA, Abji F, Liang K, Chandran V, Pellett FJ, Virtanen C, Gladman DD (2015) Gene expression differences between psoriasis patients with and without inflammatory arthritis. J Invest Dermatol 135(2):620–623PubMed
20.
Abji F, Pollock RA, Liang K, Chandran V, Gladman DD (2016) Brief report: CXCL10 is a possible biomarker for the development of psoriatic arthritis among patients with psoriasis. Arthritis Rheumatol 68(12):2911–2916PubMed
21.
Soomro M, Hum R, Barton A, Bowes J (2023) Genetic studies investigating susceptibility to psoriatic arthritis: a narrative review. Clin Ther 45(9):810–815PubMed
22.
Huffmeier U, Uebe S, Ekici AB, Bowes J, Giardina E, Korendowych E, Juneblad K, Apel M, McManus R, Ho P et al (2010) Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 42(11):996–999PubMedPubMedCentral
23.
Ellinghaus E, Stuart PE, Ellinghaus D, Nair RP, Debrus S, Raelson JV, Belouchi M, Tejasvi T, Li Y, Tsoi LC et al (2012) Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL. J Invest Dermatol 132(4):1133–1140PubMed
24.
Chandran V, Bull SB, Pellett FJ, Ayearst R, Pollock RA, Gladman DD (2014) Killer-cell immunoglobulin-like receptor gene polymorphisms and susceptibility to psoriatic arthritis. Rheumatology (Oxford) 53(2):233–239PubMed
25.
Eder L, Chandran V, Gladman DD (2015) What have we learned about genetic susceptibility in psoriasis and psoriatic arthritis? Curr Opin Rheumatol 27(1):91–98PubMed
26.
Motta F, Pederzani A, Carena MC, Ceribelli A, Wordsworth PB, De Santis M, Selmi C, Vecellio M (2021) MicroRNAs in Axial Spondylarthritis: an overview of the recent progresses in the Field with a focus on Ankylosing spondylitis and Psoriatic Arthritis. Curr Rheumatol Rep 23(8):59PubMedPubMedCentral
27.
Azuaga AB, Ramirez J, Canete JD (2023) Psoriatic arthritis: Pathogenesis and targeted therapies. Int J Mol Sci 24(5)
28.
Pollock RA, Chandran V, Pellett FJ, Thavaneswaran A, Eder L, Barrett J, Rahman P, Farewell V, Gladman DD (2013) The functional MICA-129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA-B and HLA-C. Tissue Antigens 82(1):43–47PubMed
29.
Mease PJ, Armstrong AW (2014) Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs 74(4):423–441PubMedPubMedCentral
30.
Queiro-Silva R, Torre-Alonso JC, Tinture-Eguren T, Lopez-Lagunas I (2004) The effect of HLA-DR antigens on the susceptibility to, and clinical expression of psoriatic arthritis. Scand J Rheumatol 33(5):318–322PubMed
31.
Ho PY, Barton A, Worthington J, Thomson W, Silman AJ, Bruce IN (2007) HLA-Cw6 and HLA-DRB1*07 together are associated with less severe joint disease in psoriatic arthritis. Ann Rheum Dis 66(6):807–811PubMedPubMedCentral
32.
Winchester R, Minevich G, Steshenko V, Kirby B, Kane D, Greenberg DA, FitzGerald O (2012) HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum 64(4):1134–1144PubMed
33.
Dand N, Duckworth M, Baudry D, Russell A, Curtis CJ, Lee SH, Evans I, Mason KJ, Alsharqi A, Becher G et al (2019) HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis. J Allergy Clin Immunol 143(6):2120–2130PubMed
34.
Deng M, Su Y, Wu R, Li S, Zhu Y, Tang G, Shi X, Zhou T, Zhao M, Lu Q (2022) DNA methylation markers in peripheral blood for psoriatic arthritis. J Dermatol Sci 108(1):39–47PubMed
35.
Natoli V, Charras A, Hofmann SR, Northey S, Russ S, Schulze F, McCann L, Abraham S, Hedrich CM (2023) DNA methylation patterns in CD4(+) T-cells separate psoriasis patients from healthy controls, and skin psoriasis from psoriatic arthritis. Front Immunol 14:1245876PubMedPubMedCentral
36.
Charras A, Garau J, Hofmann SR, Carlsson E, Cereda C, Russ S, Abraham S, Hedrich CM (2021) DNA methylation patterns in CD8(+) T cells discern Psoriasis from Psoriatic Arthritis and Correlate with Cutaneous Disease Activity. Front Cell Dev Biol 9:746145PubMedPubMedCentral
37.
Cruz-Correa OF, Pollock RA, Machhar R, Gladman DD (2023) Prediction of psoriatic arthritis in patients with psoriasis using DNA methylation profiles. Arthritis Rheumatol 75(12):2178–2184PubMed
38.
Haschka J, Simon D, Bayat S, Messner Z, Kampylafka E, Fagni F, Skalicky S, Hackl M, Resch H, Zwerina J et al (2023) Identification of circulating microRNA patterns in patients in psoriasis and psoriatic arthritis. Rheumatology (Oxford) 62(10):3448–3458PubMed
39.
Born LJ, Khachemoune A (2023) Extracellular vesicles: a comprehensive review of their roles as biomarkers and potential therapeutics in psoriasis and psoriatic arthritis. Clin Exp Dermatol 48(4):310–318PubMed
40.
Pasquali L, Svedbom A, Srivastava A, Rosen E, Lindqvist U, Stahle M, Pivarcsi A, Sonkoly E (2020) Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis. J Eur Acad Dermatol Venereol 34(6):1248–1256PubMed
41.
Johnsson H, Cole J, McInnes IB, Graham G, Siebert S (2024) Differences in transcriptional changes in psoriasis and psoriatic arthritis skin with immunoglobulin gene enrichment in psoriatic arthritis. Rheumatology (Oxford) 63(1):218–225PubMed
42.
Ramessur R, Corbett M, Marshall D, Acencio ML, Barbosa IA, Dand N, Di Meglio P, Haddad S, Jensen AHM, Koopmann W et al (2022) Biomarkers of disease progression in people with psoriasis: a scoping review. Br J Dermatol 187(4):481–493PubMedPubMedCentral
43.
Cretu D, Gao L, Liang K, Soosaipillai A, Diamandis EP, Chandran V (2018) Differentiating Psoriatic Arthritis from Psoriasis without Psoriatic Arthritis using Novel serum biomarkers. Arthritis Care Res (Hoboken) 70(3):454–461PubMed
44.
Chandran V, Cook RJ, Edwin J, Shen H, Pellett FJ, Shanmugarajah S, Rosen CF, Gladman DD (2010) Soluble biomarkers differentiate patients with psoriatic arthritis from those with psoriasis without arthritis. Rheumatology (Oxford) 49(7):1399–1405PubMed
45.
Ruscitti P, Esposito M, Di Cola I, Pellegrini C, De Berardinis A, Mastrangelo M, Gianneramo C, Barile A, Fargnoli MC, Cipriani P (2023) Cytokine profile characterization of naive patients with psoriasis and psoriatic arthritis: implications for a pathogenic disease continuum. Front Immunol 14:1229516PubMedPubMedCentral
46.
Holm Nielsen S, Magee C, Groen SS, Sinkeviciute D, Bay-Jensen AC, Karsdal MA, Pennington SR, FitzGerald O (2023) Differentiating patients with psoriasis from psoriatic arthritis using collagen biomarkers. Clin Exp Rheumatol 41(3):574–580PubMed
47.
Cretu D, Prassas I, Saraon P, Batruch I, Gandhi R, Diamandis EP, Chandran V (2014) Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry. Clin Proteom 11(1):27
48.
Cretu D, Liang K, Saraon P, Batruch I, Diamandis EP, Chandran V (2015) Quantitative tandem mass-spectrometry of skin tissue reveals putative psoriatic arthritis biomarkers. Clin Proteom 12(1):1
49.
Kishikawa T, Arase N, Tsuji S, Maeda Y, Nii T, Hirata J, Suzuki K, Yamamoto K, Masuda T, Ogawa K et al (2021) Large-scale plasma-metabolome analysis identifies potential biomarkers of psoriasis and its clinical subtypes. J Dermatol Sci 102(2):78–84PubMed
50.
Ambrozewicz E, Wojcik P, Wronski A, Luczaj W, Jastrzab A, Zarkovic N, Skrzydlewska E (2018) Pathophysiological alterations of Redox Signaling and Endocannabinoid System in Granulocytes and plasma of psoriatic patients. Cells 7(10)
51.
Paine A, Brookes PS, Bhattacharya S, Li D, De La Luz Garcia-Hernandez M, Tausk F, Ritchlin C (2023) Dysregulation of bile acids, lipids, and nucleotides in Psoriatic Arthritis revealed by unbiased profiling of serum metabolites. Arthritis Rheumatol 75(1):53–63PubMed
52.
Armstrong AW, Wu J, Johnson MA, Grapov D, Azizi B, Dhillon J, Fiehn O (2014) Metabolomics in psoriatic disease: pilot study reveals metabolite differences in psoriasis and psoriatic arthritis. F1000Res 3:248PubMedPubMedCentral
53.
Looby N, Roszkowska A, Reyes-Garces N, Yu M, Baczek T, Kulasingam V, Pawliszyn J, Chandran V (2021) Serum metabolic fingerprinting of psoriasis and psoriatic arthritis patients using solid-phase microextraction-liquid chromatography-high-resolution mass spectrometry. Metabolomics 17(7):59PubMedPubMedCentral
54.
Wojcik P, Biernacki M, Wronski A, Luczaj W, Waeg G, Zarkovic N, Skrzydlewska E (2019) Altered lipid metabolism in blood mononuclear cells of psoriatic patients indicates Differential Changes in Psoriasis Vulgaris and Psoriatic Arthritis. Int J Mol Sci 20(17)
55.
Coras R, Kavanaugh A, Boyd T, Huynh Q, Pedersen B, Armando AM, Dahlberg-Wright S, Marsal S, Jain M, Paravar T et al (2019) Pro- and anti-inflammatory eicosanoids in psoriatic arthritis. Metabolomics 15(4):65PubMedPubMedCentral
56.
Coras R, Kavanaugh A, Boyd T, Huynh D, Lagerborg KA, Xu YJ, Rosenthal SB, Jain M, Guma M (2019) Choline metabolite, trimethylamine N-oxide (TMAO), is associated with inflammation in psoriatic arthritis. Clin Exp Rheumatol 37(3):481–484PubMedPubMedCentral
57.
Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D, Xiao C, Zhu D, Koya JB, Wei L, Li J et al (2022) Microbiota in health and diseases. Signal Transduct Target Ther 7(1):135PubMedPubMedCentral
58.
Mahmood F, Coates LC, Helliwell PS (2018) Current concepts and unmet needs in psoriatic arthritis. Clin Rheumatol 37(2):297–305PubMed
59.
Boix-Amoros A, Badri MH, Manasson J, Blank RB, Haberman RH, Neimann AL, Girija PV, Jimenez Hernandez A, Heguy A, Koralov SB et al (2023) Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin. Ann Rheum Dis 82(4):507–514PubMed
60.
Mosaad YM (2015) Clinical role of Human Leukocyte Antigen in Health and Disease. Scand J Immunol 82(4):283–306PubMed
61.
Zhang L, Lu Q, Chang C (2020) Epigenetics in Health and Disease. Adv Exp Med Biol 1253:3–55PubMed
Metadata
Title
Differences between psoriatic arthritis and psoriasis in multi-omics
Authors
Siming Gao
Hui Song
Publication date
01-08-2024
Publisher
Springer Berlin Heidelberg
Published in
Archives of Dermatological Research / Issue 6/2024
Print ISSN: 0340-3696
Electronic ISSN: 1432-069X
DOI
https://doi.org/10.1007/s00403-024-03018-9

Other articles of this Issue 6/2024

Genetic analyses unravel the causal association of cytokine levels on lichen simplex chronicus risk: insights from a mendelian randomization study

The role of an education E-module in patient adherence and satisfaction of topical 5-fluorouracil: a pilot study

Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study

Hair loss and quality of life in muslim American women

Evaluation of the inflammatory parameters as potential biomarkers of systemic inflammation extent and the disease severity in psoriasis patients

The burden of skin diseases in China: global burden of Disease Study 2019